封面
市场调查报告书
商品编码
1887692

全球聚合酵素链锁反应市场

Polymerase Chain Reaction

出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球聚合酵素链锁反应(PCR)市场预计到2030年将达到131亿美元

全球聚合酵素链锁反应(PCR) 市场规模在 2024 年估计为 98 亿美元,预计到 2030 年将达到 131 亿美元,在分析期(2024-2030 年)内复合年增长率 (CAGR) 为 5.0%。本报告分析的仪器细分市场预计将以 4.9% 的复合年增长率成长,并在分析期结束时达到 34 亿美元。试剂和耗材细分市场预计在分析期内将以 5.0% 的复合年增长率成长。

美国市场规模估计为26亿美元,而中国市场预计将以7.6%的复合年增长率成长。

据估计,2024年美国聚合酵素链锁反应(PCR)市场规模将达26亿美元。作为世界第二大经济体,中国预计到2030年市场规模将达到29亿美元,2024年至2030年的复合年增长率(CAGR)为7.6%。其他值得关注的区域市场分析包括日本和加拿大,预计在分析期间内,这两个国家的复合年增长率分别为2.7%和4.4%。在欧洲,德国的复合年增长率预计约为2.9%。

全球聚合酵素链锁反应(PCR)市场-主要趋势与驱动因素概述

聚合酵素链锁反应:现代分子生物学的基石

聚合酵素链锁反应(PCR) 是分子生物学领域的突破性技术,能够扩增特定的 DNA 序列。 PCR 由 Kary Mullis 于 1983 年开发,使研究人员能够在相对较短的时间内将特定的 DNA 片段扩增至数百万拷贝。这个过程涉及反覆的加热和冷却循环,从而促进 DNA 双螺旋的变性、引子与目标序列的退火以及 DNA聚合酵素对这些引子的延伸。反应混合物通常包含 DNA 模板、两个引子、游离核苷酸、缓衝液和耐热 DNA聚合酵素(例如 Taq聚合酵素) ,后者能够承受变性所需的高温。这个循环过程能够指数级扩增目标 DNA 区域,使 PCR 成为遗传研究、诊断和法医学中不可或缺的工具。

PCR技术在各领域有哪些应用?

聚合酶炼式反应(PCR)具有快速、精确扩增DNA的能力,因此广泛应用于各个科学和医学领域。在医学诊断中,它用于检测和定量细菌、病毒等病原体,从而能够识别爱滋病、肝炎和新冠肺炎等感染疾病。基因检测还能辨识与遗传疾病相关的突变,有助于早期诊断和製定个人化治疗方案。在法医学中,PCR对于分析从犯罪现场采集的微量DNA样本至关重要,能够提供将嫌疑人与犯罪活动联繫起来的证据。此外,PCR在生物技术和製药行业的研发中也发挥着重要作用,用于克隆、基因表现分析以及基因改造生物的建构。 PCR的多功能性和精确性使其成为增进我们对遗传学理解、改善公共卫生和安全的关键技术。

PCR技术及其应用目前的发展趋势为何?

在分子生物学进步和对快速、精准基因分析日益增长的需求推动下,PCR技术及其应用不断发展。其中一个关键趋势是定量PCR(qPCR)或即时PCR的发展,它能够即时定量DNA和RNA,从而为基因表现和病毒量提供宝贵的资讯。数位PCR(dPCR)是一种新兴技术,它将样本分成数千个独立的反应,从而实现核酸的绝对定量,并具有高精度和高灵敏度。微流体技术的进步促成了携带式PCR设备的开发,使得在资源匮乏地区和现场进行基因检测成为可能。此外,多重PCR能够在单次反应中扩增多个靶标,透过减少时间和试剂消费量,提高了基因检测的效率。这些趋势反映了人们为提高PCR的准确性、效率和可近性,并拓展其在各个领域的潜在应用所做的持续努力。

哪些因素正在推动PCR市场的成长?

PCR市场成长受多种因素驱动,反映出对先进基因分析和诊断工具日益增长的需求。医疗领域的不断拓展,尤其是感染疾病的日益普及和对早期诊断的需求,是推动PCR技术发展的关键因素。 qPCR和dPCR等技术的进步提高了PCR的效力和准确性,促进了其在各个应用领域的普及。对个人化医疗的日益重视以及对精准基因检测以指导治疗决策的需求,也是推动市场成长的因素。此外,生物技术和製药产业研发投入的增加,也推动了药物发现和基因工程领域对PCR的需求。 PCR在法医学和环境监测领域的日益广泛应用,也进一步促进了市场扩张。持续不断的研发投入,旨在创新和改进PCR技术,确保了PCR市场的稳健成长,凸显了其在推动分子生物学发展和改善公共卫生方面的重要作用。

部分:

按最终用户(学术和研究机构、临床诊断检查室和医院、製药和生物技术产业、其他最终用户);按细分市场(设备、试剂和耗材)划分

受访公司范例

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • QIAGEN NV
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具,革新市场和竞争情报分析。

Market Glass, Inc. 并没有采用典型的 LLM 或产业专用的SLM 方法,而是建立了一个由世界各地领域专家精心策划的内容库,其中包括影片转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中,Market Glass, Inc. 将关税对地理市场的影响纳入考量,并根据公司总部所在地、製造地以及进出口(成品和OEM产品)情况,预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手,包括增加销货成本、降低盈利和重组供应链,同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP14084

Global Polymerase Chain Reaction Market to Reach US$13.1 Billion by 2030

The global market for Polymerase Chain Reaction estimated at US$9.8 Billion in the year 2024, is expected to reach US$13.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Reagents & Consumables segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 7.6% CAGR

The Polymerase Chain Reaction market in the U.S. is estimated at US$2.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Polymerase Chain Reaction Market - Key Trends and Drivers Summarized

Polymerase Chain Reaction: A Cornerstone of Modern Molecular Biology

Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of specific DNA sequences. Developed by Kary Mullis in 1983, PCR enables researchers to produce millions of copies of a particular DNA segment in a relatively short amount of time. The process involves repeated cycles of heating and cooling, which facilitate the denaturation of the DNA double helix, the annealing of primers to target sequences, and the extension of these primers by a DNA polymerase enzyme. Typically, the reaction mixture contains the DNA template, two primers, free nucleotides, a buffer solution, and the thermostable DNA polymerase, such as Taq polymerase, which can withstand the high temperatures required for denaturation. This cyclical process results in the exponential amplification of the target DNA region, making PCR an indispensable tool in genetic research, diagnostics, and forensic science.

How Is PCR Utilized Across Different Fields?

PCR is utilized extensively across various scientific and medical fields due to its ability to rapidly and accurately amplify DNA. In medical diagnostics, PCR is employed to detect and quantify pathogens, such as bacteria and viruses, enabling the identification of infections like HIV, hepatitis, and COVID-19. Genetic testing also benefits from PCR, as it can identify mutations associated with hereditary diseases, facilitating early diagnosis and personalized treatment plans. In the field of forensic science, PCR is crucial for analyzing minute DNA samples from crime scenes, providing evidence that can link suspects to criminal activities. Additionally, PCR plays a significant role in research and development within biotechnology and pharmaceutical industries, where it is used for cloning, gene expression analysis, and the creation of genetically modified organisms. The versatility and precision of PCR make it an essential technique for advancing our understanding of genetics and improving public health and safety.

What Are the Current Trends in PCR Technology and Applications?

The technology and applications of PCR are continuously evolving, driven by advancements in molecular biology and the increasing demand for rapid and accurate genetic analysis. One significant trend is the development of quantitative PCR (qPCR), also known as real-time PCR, which allows for the quantification of DNA or RNA in real-time, providing valuable insights into gene expression and viral load. Digital PCR (dPCR) is another innovation, offering higher precision and sensitivity by partitioning the sample into thousands of individual reactions, enabling absolute quantification of nucleic acids. Advances in microfluidics are leading to the creation of portable PCR devices, making it possible to conduct genetic testing in resource-limited settings or in the field. Additionally, multiplex PCR, which can amplify multiple targets in a single reaction, is enhancing the efficiency of genetic testing by reducing time and reagent consumption. These trends reflect the ongoing efforts to improve the accuracy, efficiency, and accessibility of PCR, expanding its potential applications in diverse fields.

What Factors Are Driving the Growth in the PCR Market?

The growth in the PCR market is driven by several factors, reflecting the increasing demand for advanced genetic analysis and diagnostic tools. The expansion of the healthcare sector, particularly the rising prevalence of infectious diseases and the need for early diagnosis, is a significant driver for PCR technology. Technological advancements, such as the development of qPCR and dPCR, are enhancing the capabilities and accuracy of PCR, encouraging its adoption in various applications. The growing focus on personalized medicine and the need for precise genetic testing to guide treatment decisions are also propelling market growth. Additionally, the rise in research and development activities within biotechnology and pharmaceutical industries is boosting the demand for PCR in drug discovery and genetic engineering. The increasing use of PCR in forensic science and environmental monitoring further supports market expansion. Continuous research and development efforts to innovate and improve PCR technologies ensure robust growth in the PCR market, underscoring its essential role in advancing molecular biology and improving public health outcomes.

SCOPE OF STUDY:

The report analyzes the Polymerase Chain Reaction market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector, Other End-Uses); Segment (Instruments, Reagents & Consumables)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 17 Featured) -

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • QIAGEN NV
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Polymerase Chain Reaction - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Molecular Diagnostics Propels Market Growth
    • Advances in PCR Technologies and Techniques Drives Adoption
    • Increasing Use in Infectious Disease Detection Expands Market Opportunities
    • Growth in Genetic and Genomic Research Strengthens Business Case for PCR
    • Development of Real-Time and Digital PCR Spurs Market Expansion
    • Expansion of Oncology and Cancer Research Generates Demand
    • Increasing Focus on Personalized Medicine Accelerates Market Growth
    • Enhanced Sensitivity and Specificity of Modern PCR Sustains Market Demand
    • Rising Investments in Biotechnology Research and Development Expands Addressable Market
    • Technological Innovations in PCR Reagents and Consumables Strengthens Market Position
    • Growth in Forensic and Clinical Applications Propels Market Growth
    • Increasing Demand for PCR in Agricultural and Food Testing Sustains Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Clinical Diagnostic Labs & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Pharmaceutical & Biotechnology Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Polymerase Chain Reaction Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION